Work

Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib

Year: 2015

Type: article

Study design: Case Report

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0000000000000455

Authors: Justin F. Gainor, Carol A. Sherman, Kathryn Willoughby, Jennifer Logan, Elizabeth Kennedy, Priscilla K. Brastianos, Andrew S. Chi, Alice T. Shaw

Institutions: Medical University of South Carolina, Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Massachusetts General Hospital, Medical University of South Carolina, National Cancer Institute

Awards: PROTON THERAPY RESEARCH AND TREATMENT CENTER, G417794582, G7705229639

OpenAlex ID: W2036099482

FWCI: 22.58

Cites: 26

Cited by: 168

Related to: 10